Sensei Biotherapeutics Inc Financial Flexibility Index
Sensei Biotherapeutics Inc financial flexibility index. Sensei Biotherapeutics Inc (SNSE) has a Financial Flexibility Index of -0.76x as of March 2026. Free cash flow of $-10.73 Million (operating CF $-10.73 Million minus capex $6.00K) represents -1% of total liabilities ($14.19 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sensei Biotherapeutics Inc (2018–2025)
Financial flexibility index of Sensei Biotherapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Sensei Biotherapeutics Inc across 8 annual periods. Explore Sensei Biotherapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Sensei Biotherapeutics Inc Financial Flexibility Index by Year (2018–2025)
Sensei Biotherapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Sensei Biotherapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Sensei Biotherapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.74x | $-20.44 Million | $-20.45 Million | $4.31 Million | ▼ -34.9% |
| 2024 | -3.52x | $-24.52 Million | $-24.67 Million | $6.97 Million | ▼ -4.7% |
| 2023 | -3.36x | $-31.84 Million | $-32.02 Million | $9.48 Million | ▼ -29.9% |
| 2022 | -2.59x | $-38.70 Million | $-39.03 Million | $14.97 Million | ▲ +38.5% |
| 2021 | -4.21x | $-28.23 Million | $-30.26 Million | $6.71 Million | ▼ -41.1% |
| 2020 | -2.98x | $-16.50 Million | $-17.70 Million | $5.54 Million | ▼ -2345.4% |
| 2019 | -0.12x | $-8.52 Million | $-8.57 Million | $69.88 Million | ▲ +34.4% |
| 2018 | -0.19x | $-10.28 Million | $-10.31 Million | $55.33 Million | — |